80 Spam-Free Article(s) Found
Sort:
Date
Filter:
All
Symbol Name Last Close Mkt Cap DailyStocks'
Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Thursday’s Close
RVNC Revance Therapeutics, Inc. $23.5001 $868.04M N/A
Article Searches
Biocept leads healthcare gainers; Achieve Life Sciences and Revance Therapeutics among losers https://seekingalpha.com/news/3423527-biocept-leads-healthcare-gainers-achieve-life-sciences-revance-therapeutics-among-losers?source=feed_news_all Jan 16, 2019 -
Revance Therapeutics: New Data And Partnership A Welcome Development https://seekingalpha.com/article/4226447-revance-therapeutics-new-data-partnership-welcome-development?source=feed_sector_healthcare Dec 05, 2018 - Shares have risen by just 5% since my initial article and lost a quarter of their value since my last update.I provide a recap of the bullish thesis and recent events.SAKURA phase 3 open-label data wa
Revance Therapeutics, Inc. (RVNC) CEO Daniel Browne on Q3 2018 Results - Earnings Call Transcript https://seekingalpha.com/article/4217445-revance-therapeutics-inc-rvnc-ceo-daniel-browne-q3-2018-results-earnings-call-transcript?source=feed_sector_healthcare Nov 01, 2018 - Revance Therapeutics, Inc. (NASDAQ:RVNC) Q3 2018 Earnings Conference Call November 1, 2018, 16:30 ET Executives Jeanie Herbert - Senior Director of IR & Corporate Communications Daniel Browne - Co
Revance Therapeutics: A New Contender In The Botox Arena https://seekingalpha.com/article/4205300-revance-therapeutics-new-contender-botox-arena?source=feed_sector_healthcare Sep 10, 2018 - Revance is a clinical-stage biotechnology company focused on the development and commercialization of botulinum toxin (Botox) products for cosmetic and therapeutic applications.Near-term catalysts inc
Revance Therapeutics Sees Hammer Chart Pattern: Time to Buy? http://www.zacks.com/stock/news/311720/revance-therapeutics-sees-hammer-chart-pattern-time-to-buy?cid=CS-ZC-FT-311720 Jul 17, 2018 - Revance Therapeutics Sees Hammer Chart Pattern: Time to Buy?
Allergan: Crucial Period Ahead For Company As Activist Pressure Mounts https://seekingalpha.com/article/4187408-allergan-crucial-period-ahead-company-activist-pressure-mounts?source=feed_sector_healthcare Jul 16, 2018 - Allergan is under pressure from activist shareholders and other investors to formulate a clear strategic plan and make more drastic changes to the company.Botox Aesthetics, Botox Migraine, and Restasi
Revance Therapeutics (RVNC) Pulled Back After CFO Resigned http://www.rttnews.com/story.aspx?Id=2899600 May 30, 2018 - Revance Therapeutics (RVNC) announced Tuesday morning that Lauren Silvernail has resigned as its Chief Financial Officer and Chief Business Officer.
Your Daily Pharma Scoop: ACRX NDA Accepted, BioMarin Gets Approval, Genmab Fails Study https://seekingalpha.com/article/4177559-daily-pharma-scoop-acrx-nda-accepted-biomarin-gets-approval-genmab-fails-study?source=feed_sector_healthcare May 27, 2018 - AcelRx announces FDA acceptance of NDA for DSUVIA.BioMarin’s Palynziq receives FDA approval.Genmab ofatumumab flunks late-stage NHL study.
Revance Therapeutics (RVNC) Presents At 2018 UBS Global Healthcare Conference - Slideshow https://seekingalpha.com/article/4176576-revance-therapeutics-rvnc-presents-2018-ubs-global-healthcare-conference-slideshow?source=feed_sector_healthcare May 23, 2018 - The following slide deck was published by Revance Therapeutics, Inc. in conjunction with this event.
Will Mullets Bail Out Allergan? https://seekingalpha.com/article/4173678-will-mullets-bail-allergan?source=feed_sector_healthcare May 14, 2018 - AGN is seeking strategic options to boost shareholder value.It may try to sell parts of AGN before LOE for Restasis or competition for Botox materializes.If investors buy this new narrative it could r

Pages: 123456...8

Page 1>

Related Companies

Name Exchange Price Mkt Cap
ASMB Assembly Biosciences, Inc. NASDAQ $34.41 $875.61M
RCKT Rocket Pharmaceuticals, Inc. NASDAQ $22.24 $882.06M
AMPH Amphastar Pharmaceuticals, Inc. NASDAQ $18.33 $847.88M
AMRN Amarin Corporation plc NASDAQ $2.83 $838.67M
CTMX CytomX Therapeutics, Inc. NASDAQ $18.52 $832.73M
Sector: Health Care > Industry: Major Pharmaceuticals
DeepLinks for Revance Therapeutics
RVNC - Google Finance https://www.google.com/finance?q=RVNC Industry related info and international coverage Summary News
RVNC - Bloomberg http://www.bloomberg.com/research/stocks/snapshot/snapshot.asp?ticker=RVNC Original news and commentary from Bloomberg Charts Financials with pensions Snapshot Earnings Transactions People Options